- Home
- NX vs LENZ Comparison
NX vs LENZ Comparison
Compare NX & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NX
- LENZ
- Stock Information
- Founded
- NX 1927
- LENZ 2019
- Country
- NX United States
- LENZ United States
- Employees
- NX N/A
- LENZ N/A
- Industry
- NX Metal Fabrications
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- NX Industrials
- LENZ Health Care
- Exchange
- NX Nasdaq
- LENZ Nasdaq
- Market Cap
- NX 1.1B
- LENZ 886.2M
- IPO Year
- NX N/A
- LENZ 2021
- Fundamental
- Price
- NX $22.90
- LENZ $22.36
- Analyst Decision
- NX Strong Buy
- LENZ Strong Buy
- Analyst Count
- NX 1
- LENZ 6
- Target Price
- NX $38.00
- LENZ $35.40
- AVG Volume (30 Days)
- NX 716.4K
- LENZ 184.4K
- Earning Date
- NX 03-06-2025
- LENZ 11-06-2024
- Dividend Yield
- NX 1.41%
- LENZ N/A
- EPS Growth
- NX N/A
- LENZ N/A
- EPS
- NX 0.90
- LENZ N/A
- Revenue
- NX $1,277,862,000.00
- LENZ N/A
- Revenue This Year
- NX $50.17
- LENZ N/A
- Revenue Next Year
- NX $2.87
- LENZ N/A
- P/E Ratio
- NX $25.44
- LENZ N/A
- Revenue Growth
- NX 13.03
- LENZ N/A
- 52 Week Low
- NX $21.48
- LENZ $2.57
- 52 Week High
- NX $39.31
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- NX 34.56
- LENZ 25.40
- Support Level
- NX $21.48
- LENZ $28.90
- Resistance Level
- NX $24.22
- LENZ $33.79
- Average True Range (ATR)
- NX 0.81
- LENZ 1.72
- MACD
- NX -0.05
- LENZ -0.81
- Stochastic Oscillator
- NX 36.01
- LENZ 4.71
About NX Quanex Building Products Corporation
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its three operating segments are North American Fenestration being the key revenue driver, European Fenestration, and North American Cabinet Components. Geographically, it derives a majority of revenue from the United States.
About LENZ LENZ Therapeutics Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.